The role of neuronal dendrites is to receive and process synaptic inputs. The geometry of the dendritic arbor can undergo neuronal activity-dependent changes that may impact the cognitive abilities of the organism. Here we show that vascular endothelial growth factor D (VEGFD), commonly known as an angiogenic mitogen, controls the total length and complexity of dendrites both in cultured hippocampal neurons and in the adult mouse hippocampus. VEGFD expression is dependent upon basal neuronal activity and requires nuclear calciumcalmodulin-dependent protein kinase IV (CaMKIV) signaling. Suppression of VEGFD expression in the mouse hippocampus by RNA interference causes memory impairments. Thus, nuclear calcium-VEGFD signaling mediates the effect of neuronal activity on the maintenance of dendritic arbors in the adult hippocampus and is required for cognitive functioning. These results suggest that caution be employed in the clinical use of blockers of VEGFD signaling for antiangiogenic cancer therapy.
INTRODUCTION
Many brain functions, including memory formation and acquired neuroprotection, are controlled by transient increases in the intracellular calcium concentration induced by synaptic activity (Hardingham and Bading, 2010; Silva et al., 1998) . Calcium can act locally near the site of entry to switch on signaling mechanisms that modulate several biochemical processes that in turn lead to changes in neuronal excitability and/or the efficacy of synaptic transmission (Bliss et al., 2007) . The long-term maintenance of such activity-induced, functional adaptations requires that calcium transients invade the cell nucleus and activate or repress gene expression (Hardingham and Bading, 2010; Greer and Greenberg, 2008) . Nuclear calcium is one of the most potent signals in neuronal gene expression and represents a key player in the dialog between synapse and nucleus (Zhang et al., 2009) . It controls cAMP response element binding (CREB)-and CREBbinding protein (CBP)-mediated transcription (Hardingham et al., 1997 (Hardingham et al., , 1999 (Hardingham et al., , 2001 Chawla et al., 1998; Hu et al., 1999) and is critical for the acquisition of memories and the build-up of neuroprotective activity in synaptically activated neurons (Limbä ck-Stokin et al., 2004; Papadia et al., 2005; Zhang et al., 2007 Zhang et al., , 2009 . A picture of how genomic events induced by nuclear calcium signaling regulate persistent neuroprotection is emerging (Zhang et al., 2009 (Zhang et al., , 2011 Lau and Bading, 2009 ). In contrast, nuclear calcium-regulated processes required for memory formation are unknown. Here we considered the possibility that nuclear calcium signaling modulates structural features of neurons, in particular the complexity of the dendritic arbor, that determine their ability to receive and process inputs (Cline and Haas, 2008) . The calcium/calmodulin-dependent protein kinase IV (CaMKIV), a target of calcium in the nucleus (Chow et al., 2005) , has been implicated in the regulation of dendritic growth and spine remodeling (Redmond et al., 2002; Marie et al., 2005) , suggesting that nuclear calcium may represent an important signal in these processes. In this study we identify vascular endothelial growth factor D (VEGFD), a mitogen for endothelial cells and regulator of angiogenesis and lymphatic vasculature (Lohela et al., 2009) , as a target of nuclear calciumCaMKIV signaling in hippocampal neurons. We also show that VEGFD is required for the maintenance of a complex dendritic arbor and provides the molecular link between neuronal activity, the regulation of dendritic geometry, and cognitive functioning.
RESULTS

Nuclear Calcium Controls Dendrite Geometry and Spine Density
To investigate the role of nuclear calcium signaling in the regulation of dendrite architecture, we expressed CaMBP4 in the nuclei of hippocampal neurons. This protein contains four repeats of the M13 calmodulin (CaM) binding peptide derived from the rabbit skeletal muscle myosin light chain kinase (Wang et al., 1995) . CaMBP4 effectively inactivates the nuclear calcium/ CaM complex and blocks genomic responses induced by nuclear calcium signaling (Zhang et al., 2007 (Zhang et al., , 2009 Papadia et al., 2005) . Morphometric analyses revealed that, compared to control, hippocampal neurons expressing CaMBP4 along with humanized Renilla reniformis green fluorescent protein (hrGFP) to visualize the cells showed a significant decrease both in the total dendritic length and in the complexity of the dendrites assessed by Sholl analysis (Figures 1A-1C ). Expression of CaMBP4 also caused a significant decrease in dendritic spine density ( Figures 1D and 1E ) and a considerable shortening and thinning of the remaining spines (Figures 1F and 1G) . A similar reduction in total dendritic length, dendritic complexity, spine size, and spine density was observed in hippocampal neurons expressing CaMKIVK75E, a dominant negative mutant of CaMKIV (Anderson et al., 1997) (Figure 1 ). These results indicate that nuclear calcium is an important signal in the control of dendritic geometry and spine density.
Nuclear Calcium-CaMKIV Signaling Regulates VEGFD Expression
We next aimed at identifying nuclear calcium/CaMKIV-regulated genes that mediate the observed structural changes. Examination of transcriptome data obtained from hippocampal neurons expressing CaMBP4 (Zhang et al., 2009 ) drew our attention to VEGFD (also known as Fos-induced growth factor) (Lohela et al., 2009) . VEGFD is well known for its role in angiogenesis (F and G) Cumulative frequency plots of spine length and spine width in neurons transfected as indicated. More than 1000 spines and 12 neurons from a minimum of 3 independent preparations were examined for each construct. Statistically significant differences are indicated with asterisks, **p < 0.005, ***p < 0.0005. Bars represent mean ± SEM. and lymphangiogenesis in healthy tissues and in several types of cancer (Achen and Stacker, 2008) . VEGFD is detectable in the nervous system (http://www.brainmap.org/; Lein et al., 2007) but a function for this secreted factor in neurons has not been described, although two other VEGF family members, VEGF (also known as VEGFA) and VEGFC, have been implicated in neurogenesis and the maturation of newly born neurons (Cao et al., 2004; Le Bras et al., 2006; Licht et al., 2010) . Quantitative reverse transcriptase PCR (QRT-PCR) analysis revealed that VEGFD is expressed in cultured hippocampal neurons and reaches peak levels of expression after a culturing period of 10-13 days ( Figure 2A and Figure S1A , available online). VEGFD mRNA and protein are detectable in cultured neurons and in vivo at different developmental stages in the mouse hippocampus and cortex (Figures S1C-S1F). VEGFD expression is significantly lower in hippocampal neurons infected with a recombinant adenoassociated virus (rAAV) containing an expression cassette for either CaMBP4 (rAAV-CaMBP4) or CaMKIVK75E (rAAV-CaMKIVK75E) than in uninfected neurons or in neurons infected with an rAAV-expressing LacZ (rAAV-LacZ) ( Figure 2B and Figure S1A ). The expression levels of many other genes, including other members of the VEGF family, were not affected by CaMBP4 or CaMKIVK75E (Zhang et al., 2009) (Figure S1B ). The neurotropism of our rAAVs specifically targets neurons over glia (Xu et al., 2001) indicating that the modulation of VEGFD expression is restricted to neurons.
To investigate a possible contribution of neuronal activity to VEGFD expression, we treated cultured hippocampal neurons with TTX for 5 days (from day in vitro [DIV] 5 until the time point of gene expression analysis on DIV 10). We found that compared to controls, this treatment reduced expression of VEGFD and also that of cFos, a well-characterized neuronal activity marker ( Figure 2C ). For several other genes analyzed in parallel we found no differences in expression levels after TTX treatment (Figure 2C) . Given the prolonged duration of the TTX treatment, we cannot rule out the possibility that the observed reduction in VEGFD expression may be caused indirectly through secondary effects. To determine if VEGFD mRNA levels are affected by an increase in synaptic activity, we exposed hippocampal neurons to the GABA A receptor blocker bicuculline. This treatment relieves tonic, GABA A receptor-mediated inhibition of synaptic transmission from the hippocampal network and induces bursts of action potentials (APs) (Hardingham et al., 2001; Arnold et al., 2005) . Bicuculline treatment caused a robust induction of cFos mRNA but did not alter VEGFC or VEGFD mRNA levels (Figure 2D) . To investigate the involvement of NMDA receptors and voltage-gated calcium channels in VEGFD expression, we treated hippocampal neurons with the NMDA receptor blocker MK801 and/or nifedipine, a blocker of L-type voltage-gated calcium channels. Both MK801 and nifedipine significantly reduced the expression of VEGFD mRNA; treatment with a combination of both channel blockers yielded the largest reduction in VEGFD mRNA levels ( Figure 2E ). These results indicate that VEGFD expression is controlled by basal neuronal activity through a mechanism that is initiated by NMDA receptors and (I and J) Analysis of total dendritic length and Sholl analysis of neurons infected with rAAV-E1A or rAAV-E1ADCR1. Twelve neurons from a minimum of three independent preparations were examined for each construct. Statistically significant differences are indicated with asterisks (*p < 0.05, **p < 0.005, ***p < 0.0005). Bars represent mean ± SEM. See also Figure S1 .
L-type voltage-gated calcium channels and requires nuclear calcium-CaMKIV signaling.
Because the observed reduction of VEGFD mRNA levels after inhibition of nuclear calcium signaling could be due to a change in VEGFD mRNA stability, we next determined the half-life of VEGFD mRNA. The levels of VEGFD mRNA and in parallel those of cFos were measured in both uninfected and rAAV-CaMBP4-infected hippocampal neurons before and at various time points (0.5-24 hr) after treatment of the cells with actinomycin D, an inhibitor of gene transcription. We found that VEGFD mRNA has a half-life of more than 24 hr in uninfected hippocampal neurons; a virtually identical decay rate for VEGFD was observed in rAAV-CaMBP4-infected neurons ( Figure 2F ), although compared to uninfected controls, the absolute amounts of VEGFD mRNA in these neurons were lower (see also Figure 2B and Figure S1A) . Analysis of cFos mRNA revealed a half-life of less than 1 hr ( Figure 2F ), which is in agreement with other studies (Schiavi et al., 1992) . These results indicate that the regulation of VEGFD expression by nuclear calcium signaling takes place at the level of gene transcription rather than at the posttranscriptional level.
CBP Regulates VEGFD Expression
In silico analysis with the Transcription Element Search System (TESS; http://www.cbil.upenn.edu/cgi-bin/tess/tess) of a 2000 base pairs-long upstream regulatory region of the murine VEGFD gene revealed a large number of possible binding sites for several transcription factors including the AP-1 complex, NF-AT, MEF-2, HiNF, NF-kB, POU2-Oct, and HNF4. However, a cAMP response element (CRE) appears to be lacking, suggesting that nuclear calcium-CaMKIV-mediated regulation of VEGFD takes place by transcription factors other than CREB, the prototypical target of this signaling pathway (Hardingham et al., 1997 (Hardingham et al., , 2001 . Because the activity of the transcriptional coactivator CBP is controlled by nuclear calcium and CaMKIV (Chawla et al., 1998) , we next tested the role of CBP in VEGFD regulation. CBP interacts with a variety of transcription factors (Bedford et al., 2010) , which includes some of those for which putative binding sites have been identified in the VEGFD gene (see above). Moreover, a contribution of CBP to the regulation of the human VEGFD promoter in cancer cells has been suggested (Schä fer et al., 2008) . To directly investigate a possible role of CBP in the regulation of the endogenous VEGFD gene in hippocampal neurons, we infected the neurons with an rAAV expressing the adenovirus protein E1A. E1A binds to CBP via its amino terminal-conserved region 1 (CR1) and disrupts CBP function (Arany et al., 1995; Lundblad et al., 1995; Bannister and Kouzarides, 1995) . As expected, rAAV-mediated expression of E1A blocked the AP bursting-induced increase in the expression of cFos ( Figure 2G ), a known target of the CREB/CBP transcription factor complex (Chawla et al., 1998; Hardingham et al., 1999; Greer and Greenberg, 2008) . Expression of E1A also significantly reduced VEGFD mRNA levels ( Figure 2G ). Infection of hippocampal neurons with an rAAV expressing a mutant version of E1A (E1ADCR1) that lacks CR1 and fails to interact with CBP (Arany et al., 1995; Lundblad et al., 1995; Bannister and Kouzarides, 1995) had no effect on cFos regulation or VEGFD transcription ( Figure 2G ). We also used RNA interference (RNAi) to specifically decrease CBP mRNA levels in hippocampal neurons ( Figure 2H ). This caused a significant reduction of VEGFD mRNA levels ( Figure 2H ) confirming the role of CBP in modulating VEGFD transcription. A morphometric analysis revealed that hippocampal neurons expressing E1A have shorter and simplified dendritic trees compared to neurons expressing E1ADCR1 ( Figures 2I and 2J ). These results indicate that CBP acts downstream of nuclear calcium-CaMKIV signaling to regulate VEGFD expression in hippocampal neurons.
VEGFD Restores Dendrite Complexity but Not Spine Density in Nuclear Calcium Signaling-Depleted Neurons
To investigate whether VEGFD is involved in mediating the effects of nuclear calcium-CaMKIV signaling on neuronal structure, we either transfected or infected hippocampal neurons, respectively, with an rAAV plasmid (pAAV-VEGFD) or an rAAV (rAAV-VEGFD) containing an expression cassette for HA-tagged VEGFD or we treated the neurons with recombinant VEGFD (rVEGFD). Expression of HA-tagged VEGFD was detected immunocytochemically and by immunoblotting in rAAV-VEGFD-infected hippocampal neurons and in the culture media (Figures S1G and S1H). Although VEGFD-HA expression or exogenously applied rVEGFD had no detectable effect on neuronal morphology, both treatments rescued the reduction in dendrite length and complexity caused by expression of CaMBP4 or CaMKIVK75E ( Figures 3A-3C , 3E, and 3F). In contrast, VEGFD-HA and rVEGFD failed to restore normal spine density in CaMBP4 or CaMKIVK75E-expressing neurons (Figures 3D and 3G) , indicating that the mechanisms through which nuclear calcium-CaMKIV signaling regulate dendrite geometry and spine density are distinct. Because VEGFD belongs to a family of closely related factors that in part share the receptors (Achen and Stacker, 2008) , we tested whether VEGF or VEGFC also affect dendrite arborization. However, neither recombinant VEGF (rVEGF) nor recombinant VEGFC (rVEGFC) was able to rescue the reduction in dendrite length and complexity caused by CaMBP4 or CaMKIVK75E expression ( Figure S2 ), indicating a specific role for VEGFD in the control of dendrite arborization by nuclear calcium-CaMKIV signaling.
VEGFD Autocrine Signaling Is Essential for Complex Dendritic Arborization
To determine whether the observed reduction in VEGFD expression that followed blockade of nuclear calcium-CaMKIV signaling is sufficient to alter dendritic architecture, we used RNAi to lower VEGFD expression in hippocampal neurons. DNA sequences encoding short hairpin RNAs (shRNAs) designed to target the mouse VEGFD mRNA were inserted downstream of the U6 promoter of an rAAV vector. The resulting rAAV, rAAV-shVEGFD, also harbors a calcium/calmodulin-dependent protein kinase II (CaMKII) promoter-containing expression cassette for the red fluorescent protein, mCherry ( Figure 4A ). Control rAAVs were identical to rAAV-shVEGFD except that they either lacked DNA sequences encoding shRNAs (rAAVemptymC) or contained DNA sequences encoding a scrambled version of the VEGFD-specific shRNA (rAAV-shSCR). Infection rates of 80%-95% of the neuron population were obtained for all three rAAVs (Figures S3A and S3B) . QRT-PCR and immunoblot analysis revealed that rAAV-shVEGFD, but not rAAV-shSCR or rAAV-emptymC, reduced VEGFD mRNA levels and blocked VEGFD protein expression ( Figure 4B and Figure S3C ). Expression of VEGFC was not affected by rAAV-shVEGFD or by the two control rAAVs ( Figure 4B ). It has been reported that expression of certain shRNAs can have an effect on neuronal morphology because of the induction of an interferon response (Alvarez et al., 2006) . However, by using an interferon-responsive reporter gene system we found no evidence for an interferon response induced by rAAV-shVEGFD ( Figure S3D ). In addition, we observed no increase in cell death in hippocampal neurons infected with rAAV-shVEGFD ( Figure S3E ).
Morphological analyses revealed that compared to hippocampal neurons transfected with pAAV-shSCR or pAAV-emptymC, neurons transfected with pAAV-shVEGFD showed a less complex dendritic arbor and a reduction in total dendritic length (E-G) Sholl analysis and analysis of total dendritic length and spine density of neurons transfected with expression vectors for hrGFP, CaMBP4, and CaMKIVK75E with or without treatment for 3 days with rVEGFD. Twelve neurons from a minimum of three independent preparations were examined for each construct. Statistically significant differences are indicated with asterisks (*p < 0.05, **p < 0.005, ***p < 0.0005). Bars represent mean ± SEM. See also Figure S2 .
( Figures 4C-4E ). In contrast, RNAi-mediated knockdown of VEGFD did not change spine density (number of spines/ 20 mm: 7.1 ± 0.36, pAAV-emptymC; 6.17 ± 0.56, pAAV-shSCR; 6.52 ± 0.51, pAAV-shVEGFD). Similar results were obtained with different shRNA sequences directed against VEGFD ( Figure S3F and Supplemental Experimental Procedures). The effect of pAAV-shVEGFD transfection on the dendritic tree could be reversed by treatment with rVEGFD. In contrast, rVEGFD did not affect dendrite length or complexity of hippocampal neurons transfected with pAAV-shSCR and pAAV-emptymC ( Figures 4C-4E) . These results identify a role for VEGFD in the regulation of dendritic architecture and further support the above-mentioned concept (see Figure 3 ) that dendrite arborization and spine morphogenesis are controlled by distinct nuclear calcium/CaMKIV-regulated processes.
The observation that the dendrite structure is altered in shVEGFD-expressing neurons even if the surrounding untransfected cells have a normal VEGFD expression level suggests a possible autocrine mechanism of action of VEGFD. To investigate this further, we transfected hippocampal neurons with pAAV-VEGFD-HA or with a plasmid containing an expression cassette for HA-tagged VEGFD resistant to shVEGFD (pAAVresiVEGFD-HA) together with pAAV-shVEGFD in order to overexpress VEGFD in the same neurons expressing shVEGFD. Expression of resiVEGFD-HA rescued the reduction of dendrite length and complexity caused by expression of shVEGFD ( Figures 4F-4H ), indicating that VEGFD acts in an autocrine manner. This conclusion is further supported by an experiment in which hippocampal neurons were first infected with rAAV-VEGFD and subsequently transfected with pAAV-shVEGFD. Because infection rates are very high but transfection rates are very low, this creates a situation in which a small number of transfected cells with low VEGFD expression levels and reduced dendrite length and arborization are surrounded by infected cells overexpressing VEGFD. We found that even under these conditions the impairment in dendrite morphology caused by shVEGFD cannot be overcome by the VEGFD overexpressed in the infected neurons ( Figures S3G-S3I ). Thus, although we cannot fully exclude paracrine action of VEGFD, all available evidence strongly suggests that VEGFD regulates total dendrite length and complexity through an autocrine mechanism. 
VEGFD Regulates Dendritic Arborization via VEGFR3
Human VEGFD and its close relative VEGFC can bind and activate both VEGF receptors 2 and 3 (VEGFR2 and VEGFR3); however, murine VEGFD can only activate VEGFR3 . To investigate whether dendritic architecture is specifically controlled by VEGFD acting via VEGFR3, we generated rAAVs expressing shRNAs specific for VEGF (rAAV-shVEGF), VEGFC (rAAVshVEGFC), and VEGFR3 (rAAV-shVEGFR3) (Wong et al., 2005; Kleinman et al., 2008) . By using QRT-PCR we showed that rAAV-shVEGF, rAAV-shVEGFC, rAAV-shVEGFR3, and rAAVshVEGFD reduced mRNA levels of their respective targets leaving unaltered the expression of the other VEGF family members ( Figure 5A ). Morphological analyses revealed that transfection of hippocampal neurons with pAAV-shVEGF or pAAV-shVEGFC, similar to transfection with the control plasmids, pAAV-shSCR or pAAV-emptymC, had no effect on dendrite length or complexity (Figures 5B-5D ). In contrast, knockdown of VEGFR3 by transfecting neurons with pAVV-shVEGFR3 led to changes in the dendritic structure that were virtually identical to those obtained in hippocampal neurons transfected with pAAV-shVEGFD (Figures 5B-5D ; see also Figures 4C-4H and Figures S3G-S3I for the effects of pAAV-shVEGFD on dendrite morphology). These results indicate that among VEGF family members, VEGFD, acting through VEGFR3, plays a specific role in the regulation of dendrite arborization.
VEGFD Regulates Multiple Signaling Pathways in Hippocampal Neurons and Shapes Dendrite Morphology via p38 MAP Kinase Activation
We next determined the signaling mechanisms through which VEGFD controls dendrite architecture. Cell lysates from hippo- campal neurons treated with rVEGFD for various lengths of time were subjected to immunoblot analysis by using a large panel of antibodies that are specific for the phosphorylated (i.e., activated) forms of signaling molecules (Figure 6) . We found that rVEGFD activates ERK1/2, p38 MAP kinase (MAPK), and CREB ( Figures 6A and 6B ). The increase in ERK1/2 phosphorylation and CREB phosphorylation (which takes place in neurons and not in glial cells as shown by double immunostaining with the neuronal marker NeuN; Figure 6C ) was significant but moderate ( Figures 6A  and 6B ). In contrast, the activation of p38 MAPK was very robust ( Figures 6A  and 6B ), indicating that it may be a major transducer of VEGFD signaling in hippocampal neurons. We therefore determined whether p38 MAPK mediates the effects of VEGFD on dendrite geometry. Indeed, selective blockade of p38 MAPK by using the p38 MAPK inhibitor SB203580 severely compromised the ability of rVEGFD to rescue the impairment of dendrite length and complexity in hippocampal neurons expressing CaMBP4 and CaM-KIVK75E (Figures 6D and 6E ; see also Figures 3A, 3E , and 3F). Because SB203580 inhibits the alpha and beta isoforms of p38 MAPK (Bain et al., 2007) , we further investigated the role of p38 MAPK in VEGFD-mediated dendritic arborization by RNAi. We generated two pAAVs, shp38a and shp38b, that contain expression cassettes for shRNAs specific for the alpha and the beta isoform, respectively, of p38 MAPK. We found that the reduction of p38 alpha MAPK expression prevented the rVEGFD-induced rescue of the dendrite phenotypes of hippocampal neurons expressing CaMBP4 ( Figure 6F ). These results indicate that p38 alpha MAPK is required for VEGFD regulation of dendrite architecture.
VEGFD Modulates Network Activity
To investigate whether VEGFD-regulated changes in the structure of dendrites are associated with changes in neuronal network activity, we used microelectrode array (MEA) recordings. Indeed, the spike frequencies of hippocampal cultures infected with rAAV-shVEGFD were reduced compared to cultures . Sholl analysis data of neurons expressing hrGFP, CaMBP4, or CaMKIVK75E treated with SB203580 showed no difference compared to the respective untreated controls and were omitted from the graph for clarity. (F) Analysis of total dendritic length of neurons transfected with expression vectors for hrGFP, CaMBP4, shSCR, shp38a or shp38b (as indicated) with or without treatment for 3 days with rVEGFD. Twelve neurons from a minimum of three independent preparations were examined for each experimental condition. Statistically significant differences are indicated with asterisks (*p < 0.05, **p < 0.005, ***p < 0.0005). Bars represent mean ± SEM.
infected with rAAV-shSCR or rAAVemptymC. This decrease could be partly rescued by the addition of rVEGFD to the media ( Figure 7A ). The decrease in network activity caused by infection with rAAV-shVEGFD was first observed at DIV 10 ( Figure 7A) , coinciding with the onset of robust VEGFD mRNA expression in vitro (see Figure 2A and Figure S1A ).
Patch-Clamp Recordings Verify Reduced Surface Area and Excitability after Silencing VEGFD Expression
The effects of silencing VEGFD expression on the electrical properties of neurons were investigated with whole-cell patch clamp recordings (Table S1 and Figure 7B ). Neurons either transfected with pAAV-shVEGFD or infected with rAAV-shVEGFD showed, in comparison to their respective control group, a markedly smaller membrane capacitance indicative of a reduced plasma membrane surface area, a finding consistent with the observed reduction in dendritic arborization (Figures 4 and 5) . Despite this difference, shVEGFD-expressing neurons did not show an altered resting membrane potential or threshold membrane potential for action potential initiation (Table S1 ). This reflects the healthy integrity of these neurons despite their altered morphology. Slightly more current injection was necessary to elicit an action potential in shVEGFD-expressing cells, although this trend was only significant in the group of hippocampal neurons in which infection was used to express shVEGFD (Table S1 ). Moreover, we found stronger accommodation in spike patterns induced by square wave current injections in shVEGFD-expressing neurons (data not shown). This suggests a mildly reduced excitability in shVEGFD-expressing neurons, consistent with the reduced absolute spike frequency identified with MEA recordings (see Figure 7A) . Increased accommodation may be due to a reduced contribution of dendritic sodium channels, h-channels, or calcium-activated potassium channels, which in pyramidal neurons can drive slow repetitive firing and influence burst waveforms. Table S1 .
Lowering VEGFD Expression Reduces the Number of Functional AMPA Receptors
The influence of VEGFD expression on synaptic transmission in hippocampal neurons in culture was directly assessed by recording miniature excitatory postsynaptic currents (mEPSCs) in the presence of TTX and the GABA A receptor blocker, gabazine. Neurons transfected with pAAV-shVEGFD or infected with rAAV-shVEGFD showed longer mEPSC interevent intervals (IEIs, 1/frequency) and smaller mEPSC amplitudes than their respective shSCRexpressing controls (Figures 7E and 7F) . The reduced mEPSC frequency in transfected hippocampal neurons suggests that the effect was not mediated by a reduced release probability presynaptically because the low transfection rate ensures that the majority of synaptic input to shRNA-expressing cells comes from non-shRNA-expressing cells. The reduced mEPSC frequency is thus most likely indicative of fewer AMPA receptorcontaining synapses per cell. The 21%-24% reduction in mEPSC amplitude also suggests a lower density of AMPA receptors at synapses in shVEGFD-expressing cells. mEPSCs of hippocampal neurons expressing shVEGFD also showed faster rise and decay time constants than their respective shSCR-expressing controls ( Figure 7C and Table S1 ), most likely due to reduced filtering of mEPSCs in their more compact dendritic trees. Alternatively, a synaptic NMDA receptor-mediated slow component of the mEPSC may have been reduced in shVEGFD-expressing neurons, although significant NMDA currents are unlikely in our recording conditions (À71 mV holding potential, 1.3 mM Mg 2+ ). Responses were also recorded to bath-applied AMPA, which produced a peak within 30 s whose amplitude was used as an indication of the total number of functional AMPA receptors per cell ( Figure 7D ). AMPA response amplitudes were smaller in hippocampal neurons expressing shVEGFD ( Figures 7D and 7G ), indicative of a reduced total number of surface-expressed AMPA receptors per cell. Taken together, our patch-clamp analysis has identified a reduced plasma membrane surface area, as well as a reduced number of AMPA receptor-containing synapses, a reduced number of AMPA receptors per synapse, and a reduced total number of AMPA receptors in shVEGFD-expressing cells. These results are consistent with the reduced dendritic morphology identified by morphometric analyses.
VEGFD Shapes Dendritic Arborization In Vivo
We next investigated the role of VEGFD in vivo. rAAV-shVEGFD or the appropriate control rAAVs were stereotaxically delivered to the dorsal hippocampus of 2-month-old C57BL/6 male mice. Infected neurons were readily identified by analysis of the mCherry fluorescence ( Figure S4 ). The morphology of neurons in the CA1 area of the hippocampus was assessed by manually tracing the basal dendrites of Golgi-stained brain slices obtained from animals 2.5 weeks after viral gene delivery. As in cultured neurons, infection of hippocampal neurons in vivo with rAAV-shVEGFD, but not with rAAV-shSCR or rAAV-emptymC, reduced both the total length of dendrites and their complexity ( Figures 8A-8C ).
VEGFD Is Required for Memory Formation
We finally investigated whether the changes in neuronal structure induced by RNAi-mediated knockdown of VEGFD causes cognitive deficits. Mice stereotaxically injected with rAAVshVEGFD or rAAV-shSCR into the hippocampus were tested in two well-characterized hippocampus-dependent memory tests: Morris water maze and contextual fear conditioning. In the hidden-platform version of the Morris water maze, mice learn the location of the platform by using distal visual cues (Morris et al., 1982) . We found that mice stereotaxically injected with rAAV-shSCR or rAAV-shVEGFD needed significantly less time to find the hidden platform across training trials (main effect of training session: F[7,91] = 11.30, p < 0.0001); however, no effect of treatment was observed (main effect of treatment: F[1,13] = 1.34, p = NS) ( Figure 8D ). This suggests that both groups have developed a learning strategy to find the hidden platform. Multiple behavioral strategies may be employed by the mice to obtain the reward (escape from water) and some of these strategies may be comparably efficient but distinct in the requirement for hippocampal function (Lipp and Wolfer, 1998; Gerlai, 2001 ).
To assess spatial memory, we performed a probe trial during which the platform was removed from the water maze and the mice were given 60 s to search for it. The search pattern during the probe trial can reveal a spatial preference that is believed to represent spatial memory. We observed that rAAV-shSCRinjected mice show a spatial preference for the target quadrant, whereas rAAV-shVEGFD-injected mice did not ( Figure 8E ). This was expressed as a significantly longer time spent in the target quadrant by the rAAV-shSCR-injected mice in comparison to the other quadrants (one-way analysis of variance [ANOVA]: F[3,28] = 9.84, p < 0.001; multiple post hoc comparisons: time in target quadrant versus time in adjacent or opposite quadrants; p < 0.05). In contrast, rAAV-shVEGFD-injected mice spent similar amounts of time in the different quadrants (F[3,24] = 1.2, p = NS). This suggests that the rAAV-shVEGFD-injected mice did not develop a spatial searching strategy, pointing to spatial memory impairment in these mice. Swimming speed was not different between the two groups ( Figure 8F , main effect of treatment: F[1,13] = 3.94, p = NS).
To determine whether abnormalities in motivation, motor coordination, or vision could account for the deficit in spatial memory, we also trained mice on a visible-platform version of the water maze, a hippocampus-independent task. In this task, the mice use a proximal, visual cue to locate the platform (Figure 8G) . rAAV-shSCR-and rAAV-shVEGFD-injected mice showed similar escape latencies to find the visible platform (main effect of training session: F[2,26] = 7.12, p < 0.01; main effect of treatment: F[1,13] = 0.36, p = NS), demonstrating that both groups acquired the task ( Figure 8G ). Overall, these results suggest that rAAV-shVEGFD-injected mice have impaired spatial memory.
In the contextual fear conditioning, mice learn the association between an aversive stimulus, a mild foot shock, and the context in which it was delivered. In mice that have formed an associative memory, a second exposure to the same context induces a fearful response expressed as freezing or immobility, parameters used to quantify the formation of memory (Maren, 2001) . We found that mice stereotaxically injected with rAAV-shVEGFD showed significantly lower levels of freezing during the 24 hr test session than did mice injected with rAAV-shSCR ( Figure 8H ). The reduction in freezing levels was not due to decreased locomotor activity or pain sensitivity because the basal exploratory activity and reaction to shock during the training session were not different between the two groups ( Figures 8I and 8J ). These findings together with the results obtained with the Morris water maze indicate that VEGFD is important for memory formation.
DISCUSSION
In this study, we identify VEGFD as a regulator of neuronal dendrite geometry. VEGFD mediates the effects of synaptic activity and nuclear calcium-CaMKIV signaling on the maintenance of complex dendrite arborization, which is necessary for memory formation.
Nuclear Calcium, Dendrite Geometry, and Cognition Neurons, even once fully developed, remain plastic and undergo activity-dependent functional or structural alterations. Changes in gene expression -induced by synaptic activity and calcium transients propagating toward and into the nucleus (Chawla et al., 1998; Hardingham et al., 1997 Hardingham et al., , 2001 Zhang et al., 2009 ) -are often essential for the long-term maintenance of adaptive responses (Hardingham and Bading, 2010; Greer and Greenberg, 2008) . Dendritic trees, the branched projections of the inputreceiving ends of neurons, are prime targets for activity-regulated structural alterations. The geometry of dendrites specifies the connectivity of neurons and strongly influences how signals are integrated and transmitted to the cell soma and therefore also which output is produced. Changes in the lengths and branching patterns of dendrites would be expected to alter not only the performance of a neuron but also the computational power of the network the neuron is part of, ultimately causing changes in the organism's behavior. Support for such a link between dendritic architecture and cognitive abilities comes from theoretical considerations and mathematical modeling (Hä usser et al., 2000; Segev and London, 2000) as well as from brain morphology studies of neurological diseases. In particular, shortening and simplification of dendrites have been observed in a variety of disorders that are associated with mental retardation or cognitive deficits, including genetic abnormalities, such as Down syndrome or Rett syndrome (Kaufmann and Moser, 2000) , neurodegenerative conditions, including Alzheimer's disease and aging (Dickstein et al., 2007) , metabolic dysfunctions (DeLong, 1993; Patil et al., 2007) , and infection with human immunodeficiency virus (Masliah et al., 1997) . Intrinsic, predetermined genetic programs and cell-autonomous mechanisms have been shown to determine dendrite morphogenesis in developing neurons (I) Speed of movement during the 2 s electric foot shock delivered in training session of animals represented in (H) (rAAV-shVEGFD, n = 10; rAAVshSCR n = 11). (J) Distance traveled during the initial 2.5 min exposure to the training chamber of animals represented in (H) (rAAV-shVEGFD, n = 10; rAAVshSCR, n = 11). Statistically significant differences (ANOVA followed by Tukey's post hoc test for morphometric, repeated-measures ANOVA and one-way ANOVA followed by Tukey's post hoc test for Morris water maze and Student's t test for behavioral analysis) are indicated with asterisks (*p < 0.05, **p < 0.005, ***p < 0.0005). Bars represent mean ± SEM. See also Figure S4 . (Kim et al., 2009; Goodman, 1978; Jan and Jan, 2003; Goldberg, 2004; Corty et al., 2009 ). However, there is an increasing appreciation of the influence of the electrical activity of neurons on dendrite arborization (Zhang and Poo, 2001; Chen and Ghosh, 2005) . We show here that VEGFD plays a central role in this process; as a target of nuclear calcium-CaMKIV signaling, it links basal neuronal activity to the control of total dendrite length and branching patterns, thereby providing neurons of the adult nervous system with the structural features needed for proper cognitive performance of the organism. These findings explain why interference either with nuclear calcium signaling or with CaMKIV activity compromises the ability of mice to form longterm memories (Limbä ck-Stokin et al., 2004; Kang et al., 2001) . They also suggest a generally applicable concept, in which impairments of synaptic transmission, e.g., because of synapse loss in aging or Alzheimer's disease (LaFerla, 2002; Shankar et al., 2007; Kuchibhotla et al., 2008) and/or malfunctioning of activityinduced calcium signaling toward and within the cell nucleus (''nuclear calciopathy,' ' Zhang et al., 2011 ) may lead to a decrease in VEGFD expression, followed by a reduction in dendrite complexity, and finally, an emergence of cognitive deficits. Strategies aimed at maintaining or restoring appropriate dendrite lengths and branching patterns-either through supplementation of VEGFD or enhancement of nuclear calcium signaling-may therefore represent avenues for the development of effective therapies for age-and disease-related cognitive dysfunction.
Anti-VEGFD Cancer Treatment and Compromised Brain Function
Several members of the VEGF family, including VEGFD, are wellknown angiogenic and lymphangiogenic mitogens that drive the formation of blood vessels and lymphatic vasculature in healthy tissues. VEGFD can also enhance the formation of tumor lymphatics, thereby promoting tumor growth and the lymphatic spread of cancer cells . Indeed, VEGFD levels in cancer patients correlate with parameters that indicate a poor clinical prognosis (Achen and Stacker, 2008) . Consequently, tremendous efforts are presently being directed toward the development and use of VEGF-targeted drugs as antiangiogenic and antilymphangiogenic treatments. These drugs are intended to inhibit the growth of tumors by cutting off their blood supply and blocking the metastatic spread of tumor cells to lymph nodes via the lymphatic vasculature (Heath and Bicknell, 2009 ). The unexpected role we have uncovered for VEGFD in the control of dendritic architecture and cognitive function thus calls for caution in the use of blockers of VEGFD signaling as a cancer therapy.
EXPERIMENTAL PROCEDURES Hippocampal Cultures and Transfection
Hippocampal neurons from newborn C57BL/6 mice were cultured as described (Bading and Greenberg, 1991; Zhang et al., 2011) . Experiments were done after a culturing period of 10-14 DIV. DNA transfection was done on DIV 8 by using Lipofectamine 2000 (Invitrogen, San Diego, CA) as described (Wiegert et al., 2007) . For the studies on dendrite morphology, neurons were analyzed 4-5 days after transfection.
Stereotaxic Delivery of rAAVs rAAVs were delivered by stereotaxic injection into the right dorsal hippocampus of 2-month-old male C57BL/6 mice. For the Golgi staining-based morphometric analysis, viral particles were unilaterally injected over a period of 20 min at the following coordinates relative to Bregma: anteroposterior, À2.1 mm; mediolateral, À1.4 mm; and dorsoventral, À1.4 to À1.8 mm from the skull surface. For behavior experiments mice were injected bilaterally.
Morphometric Analyses
For three-dimensional Sholl analysis (Sholl, 1953) , total dendritic length and spine morphology were calculated by using Object-Image freeware software with a specific set of macros (written by Dr. E. Ruthazer, McGill University, Quebec, Canada). Briefly, a z-stack acquisition was imported, calibrated in Object-Image, and manually traced. Total dendritic length was then computed. For Sholl analysis, the shell interval was set at 5 mm. All analyses were performed blind. In all in vitro experiments, for each condition, a minimum of 12 neurons from 3 independent preparations was analyzed. For the Golgi staining, quantifications of 20 neurons for each condition from 4 different injected animals per viral construct were traced and analyzed.
MEA Recordings
MEA recordings were done as described (Arnold et al., 2005) . From DIV 7 to DIV 13, recordings of spontaneous network activity were acquired for 5 min once per day.
Patch-Clamp Recordings
Whole-cell patch-clamp recordings were made at room temperature from cultured hippocampal neurons plated on coverslips secured with a platinum ring in a recording chamber (Open Access Chamber-1, Science Products GmbH, Hofheim, Germany) mounted on a fixed-stage upright microscope (BX51WI, Olympus, Hamburg, Germany). Differential interference contrast optics, infrared illumination, and a CCD camera (PCO, Visitron Systems, Puchheim, Germany) connected to a contrast enhancement unit (Argus, Hamamatsu, Herrsching am Ammersee, Germany) were used to view neurons on a video monitor. Recordings were made with a Multiclamp 700A amplifier, digitized through a Digidata 1322A A/D converter, and acquired by using pClamp software (Molecular Devices, Sunnyvale, CA). All membrane potentials were corrected for the calculated junction potential of À11 mV (JPCalc program by Dr. Peter H. Barry). mEPSCs and whole-cell AMPA (10 mM, 6 ml/min, Biotrend) responses were recorded as previously described (Wiegert et al., 2009 ) except for the solutions (see Supplemental Information) and except that a holding potential of -71 mV was used and both TTX (1 mM, Biotrend, Cologne, Germany) and gabazine (5 mM, Biotrend) were included in the ACSF. TTX was applied before gabazine to prevent the induction of action potential bursting. Access (7-18 MU) and membrane resistance (see Table  S1 ) were monitored before and after mEPSC recordings and data were rejected if changes greater than 20% occurred.
Behavioral Experiments
The behavioral experiments started 3 weeks after stereotaxic delivery of rAAVs. Mice were habituated to the experimental room and handled once a day for 3 consecutive days before testing started. Two different sets of mice were used for Morris water maze and contextual fear conditioning experiments. At the end of the experiments, virus infection was assessed. For details on the behavioral experiments see Supplemental Information.
Data Analysis
All plotted data represent mean ± SEM. ANOVA with Tukey's post hoc test was used for statistical analyses except where stated otherwise. In those experiments where only two conditions are tested, comparisons were made by using a Student's t test for independent samples. In the Morris water maze experiment, repeated-measures ANOVA and one-way ANOVA were used to analyze acquisition curves and probe trials, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j.neuron.2011.04.022.
